About St.Elisabeth-Krankenhaus Brustzentrum
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
2
Fondazione Michelangelo
1
Clinical Trials at St.Elisabeth-Krankenhaus Brustzentrum
During the past decade, St.Elisabeth-Krankenhaus Brustzentrum conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Neoadjuvant Chemotherapy With Nab-paclitaxel in Women With HER2-negative High-risk Breast Cancer
2013-04-01
2025-10-01
Active, not recruiting
632
A Study of Atezolizumab in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Participants With Previously Untreated Metastatic Triple-Negative Breast Cancer (IMpassion130)
2015-06-23
2021-08-31
Completed
902
A Study of Trastuzumab Emtansine in Combination With Atezolizumab or Placebo as a Treatment for Participants With Human Epidermal Growth Factor 2 (HER2)-Positive and Programmed Death-ligand 1 (PD-L1)-Positive Locally Advanced (LABC) or Metastatic Breast Cancer (MBC)
2021-06-07
2029-12-31
Active, not recruiting
96
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at St.Elisabeth-Krankenhaus Brustzentrum
According to Clinical.Site data, the most researched conditions in "St.Elisabeth-Krankenhaus Brustzentrum" are
"Breast Cancer" (1 trials), "Metastatic Breast Cancer" (1 trials) and "Triple Negative Breast Cancer" (1 trials). Many other conditions were trialed in "St.Elisabeth-Krankenhaus Brustzentrum" in a lesser frequency.
Clinical Trials Intervention Types at St.Elisabeth-Krankenhaus Brustzentrum
Most popular intervention types in "St.Elisabeth-Krankenhaus Brustzentrum" are "Drug" (3 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (2 trials), "Abraxane" (1 trials), "Atezolizumab" (1 trials), "Atezolizumab (MPDL3280A), an engineered anti-PDL1 antibody" (1 trials) and "Nab-Paclitaxel" (1 trials). Other intervention names were less common.
Clinical Trials Genders at St.Elisabeth-Krankenhaus Brustzentrum
The vast majority of trials in "St.Elisabeth-Krankenhaus Brustzentrum" are
2 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at St.Elisabeth-Krankenhaus Brustzentrum
Currently, there are NaN active trials in "St.Elisabeth-Krankenhaus Brustzentrum".
undefined are not yet recruiting,
undefined are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in St.Elisabeth-Krankenhaus Brustzentrum,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in St.Elisabeth-Krankenhaus Brustzentrum, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".